Share: 
Status: 
Active
Rating: 
No votes yet
0

Improving Global Outcomes in Patients with Hepatitis C Infection in Late Stage Chronic Kidney Disease (A Knowledge-Based Activity)

Course description

This activity will address the management of hepatitis C virus (HCV) in patients with advanced chronic kidney disease (CKD). Screening and treatment will be discussed. Clinical evidence for novel antivirals will also be included.

Learning Objectives: 

After participation in this activity, learners will be able to:

  • Recognize the importance of routine screening and evaluation of chronic kidney disease (CKD) patients at risk for hepatitis C virus (HCV) infection
  • Describe the role that severely impaired renal function has on HCV treatment options for HCV infected patients
  • Review late stage clinical trial data for anti-HCV therapy in patients with stage 5 and 5D CKD
  • Identify anti-HCV agents in late stage development that may be used in patients post renal transplant
PLEASE NOTE: YOU MUST LOGIN OR CREATE AN ACCOUNT BEFORE ENROLLING IN THIS EDUCATIONAL ACTIVITY. 

Once you're logged in the "ADD TO CART" button can be found at the bottom of this webpage.

Target audience: 
  • Physicians
  • Physician Assistants
  • Nurse Practitioners
  • Nurses
  • Pharmacists
  • Dietitians
CME/CE Information:

Physician

The National Kidney Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Kidney Foundation designates this enduring for a maximum of 1.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Physician Assistant

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.5 hours of Category I credit for completing this program.

Nurse Practitioners

This program is approved for 1.5 contact hours of continuing education (which includes 0.58 hours of pharmacology) by the American Association of Nurse Practitioners. Program ID 16062210.

This program was planned in accordance with AANP CE Standards and Policies.  

Nurse

The National Kidney Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.5 contact hours of continuing nursing education (includes 0.58 contact hour in the area of pharmacology).

Dietitian

The National Kidney Foundation is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR).  CDR Credentialed Practitioners will receive 1.5 Continuing Professional Education Units (CPEUs) for completion of this activity/material.

Pharmacist

The University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.  Reading the learning objectives and faculty disclosures; participating in the entire knowledge-based activity, completion of the pre-test, active learning activity, post-test (minimum score of 70% required; may be taken up to 3 times) and electronic pharmacist activity evaluation; estimating duration of time spent on the activity; and submission of NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credits.  This knowledge-based activity has been assigned ACPE Universal Activity Number 0016-9999-16-050-H01-P, for 1.5 contact hours (0.15CEUs).  All ACPE credit awarded to participants must be uploaded to CPE Monitor ™ within 30 days of the activity date, so pharmacists and pharmacy technicians are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity.  Please contact pharmce@uic.edu if you do not see activity information listed within 30 days.  For more information and to set up your e-Profile visit: www.MyCPEmonitor.net.

Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; participate in the entire self-study consisting of slides and audio; and complete the post-test (minimum score of 70% required) and evaluation to successfully earn credit.  The estimated time for completion is 1.5 hours. 

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

Disclaimer:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Credits & accreditation
  • 1.50 AANP Contact Hours
  • 1.50 ACPE Contact Hours
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 ANCC Nurse Contact Hours
  • 1.50 Attendance
  • 0.58 AANP Pharmacology
  • 0.58 ANCC Pharmacology
  • 1.50 Category I Credit for Physician Assistants
  • 1.50 CDR CPEUs
Faculty & disclosure
Faculty Disclosures:

Matthew Weir, MD
Professor and Director, Division of Nephrology
University of Maryland School of Medicine
Baltimore, MD
Disclosure: Is a consultant for Relypsa in the area of hyperkalemia; is a consultant for Akebia, Amgen, and Sandoz in the area of anemia; is a consultant for Janssen, Astra, BI, and Lexicon in the area of diabetes; is a consultant for Boston Scientific in the area of hypertension.

David Roth, MD
Professor of Medicine
University of Miami Miller School of Medicine
Miami, FL
Disclosure: Is a consultant for Merck in the area of hepatitis C virus treatments.

Roy Bloom, MD
Medical Director, Kidney/Pancreas Transplant Program
Professor of Medicine
Hospital of the University of Pennsylvania
Philadelphia, PA
Disclosure: Is a consultant for Abbvie in the area of treating HCV in patients with kidney disease.

Planning Committee Disclosures:

Matthew Weir, MD
Professor and Director, Division of Nephrology
University of Maryland School of Medicine
Baltimore, MD
Disclosure: Is a consultant for Relypsa in the area of hyperkalemia; is a consultant for Akebia, Amgen, and Sandoz in the area of anemia; is a consultant for Janssen, Astra, BI, and Lexicon in the area of diabetes; is a consultant for Boston Scientific in the area of hypertension.

David Roth, MD
Professor of Medicine
University of Miami Miller School of Medicine
Miami, FL
Disclosure: Is a consultant for Merck in the area of hepatitis C virus treatments.

Roy Bloom, MD
Medical Director, Kidney/Pancreas Transplant Program
Professor of Medicine
Hospital of the University of Pennsylvania
Philadelphia, PA
Disclosure: Is a consultant for Abbvie in the area of treating HCV in patients with kidney disease.

Sue Cary, MN, RN, ANP-BC, CNN
Adult Neprology Nurse Practitioner
Ochsner Nephrology
Baton Rouge, LA
Disclosure: Is a member of an Advisory Board for Amgen in the area of bone disease.

Katie Cardone, PharmD
Associate Professor of Pharmacy Practice
Albany College of Pharmacy and Health Sciences
Albany, NY
Disclosure: Received a research grant from GE Global Research in the area of dialysis/cardiovascular; is a consultant for Fresenius Medical Care in the area of dialysis; spouse employed by Fresenius Medical Care in the area of dialysis.

James Papanikolaw, MA
Program Director
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Nathalie Harden
Director, CME
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Anna Okoniewski
CME/CE Activities Manager
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

CME/CE Reviewer Disclosures:

Anil Agarwal, MD, FACP, FASN, FNKF
Professor of Medicine
The Ohio State University
Columbus, OH
Disclosure: Is a member of the Advisory Board for Amgen, Alexion, and Hospira; and received a research grant from Merit Medical.

Gladys Benavente, MSN, ANP-c, CNN-NP
Renal Nurse Practitioner/Primary Care Provider
Southern AZ VA Healthcare System
Tucson, AZ
Disclosure: Has no financial relationships with commercial interest(s).

Linda Gross, MS, RDN, LDN
Renal Dietitian
Fresenius Medical Care
Charlotte, NC
Disclosure: Has no financial relationships with commercial interest(s).

The University of Illinois Chicago College of Pharmacy
Office of Continuing Education and Meeting Services
Chicago, IL
Disclosure: No financial relationships with commercial interest(s).

Supported by an educational grant by Merck & Co., Inc.

Additional information
Required hardware / software: 

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to CMEinfo@kidney.org or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit http://www.kidney.org/

For additional professional education resources, contact NKF at 1-800-622-9010 or visit https://www.kidney.org/professionals 

Course summary
Available credit: 
  • 1.50 AANP Contact Hours
  • 1.50 ACPE Contact Hours
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 ANCC Nurse Contact Hours
  • 1.50 Attendance
  • 0.58 AANP Pharmacology
  • 0.58 ANCC Pharmacology
  • 1.50 Category I Credit for Physician Assistants
  • 1.50 CDR CPEUs
Course opens: 
07/12/2016
Course expires: 
07/12/2017
Cost:
$0.00

Enrollment Restricted

Please login or register for a PERC account to take this course.